In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 4, 2001, Pages 199-207

  Khan, I ^a   Al Awadi, F M ^a   Thomas, N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTISENSE OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE IK 6; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOOXYGENASE 2 SELECTIVE PHOSPHOROTHIOATE OLIGONUCLEOTIDE DERIVATIVE; MESSENGER RNA; MYELOPEROXIDASE; PHOSPHOROTHIOIC ACID DERIVATIVE; PROSTAGLANDIN E2; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN SECONDARY STRUCTURE; RAT;

EID: 0034843625     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001317022205     Document Type: Article

References (29)

1. Perspectives in antisense therapeutics
2. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation: Implications for future anti-inflammatory therapy
3. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding
4. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
5. 2
6. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions
7. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
8. Metabolism of antisense oligonucleotides in rat liver homogenates
9. Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression
10. Antisense oligonucleotides as therapeutic agents
11. Toxicological properties of several novel oligonucleotide analogs in mice
12. Colonic muscle enhances the production of interleukin-1β messenger RNA in experimental colitis
13. + exchanger isoform NHE-1
14. Effectiveness and target selectivity of the antisense oligonucleotides against cyclooxygenase-2: A potential for antisense gene therapy
15. Polymerase chain reaction assay of mRNA using 28S rRNA as internal standard
16. 2 biosynthesis in cyclooxygenase 1 or 2 null cells
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
19. Hapten-induced model of chronic inflammation and ulceration in the rat colon
20. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: Enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide
21. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
22. Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice
23. Studies on the contribution of c-fos/AP-1 to athritic joint destruction
24. Overview-mechanism of action of anti-inflammatory drugs
25. Mechanism of action of nonsteroidal anti-inflammatory drugs
26. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
27. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
28. Prostaglandin endoperoxide synthase: Why two isoforms?
29. Role of prostaglandins in gastrodudenal mucosal protection